SENSEX NIFTY

Religare Capital Markets

Mar 30, 2015 at 16:54 | Source: Moneycontrol.com
It was a strong start to the truncated week as bulls fully charged on Monday, pushing the Sensex above 28000-mark and the Nifty above 8500 intraday following positive global cues. Banking & financials, FMCG, capital goods and IT stocks helped the market gain nearly 2 percent.
Mar 30, 2015 at 16:31 | Source: CNBC-TV18
Despite the new government coming in, despite optimism in the country, despite great Budget propensity to raise capital in primary market in this country is very subdued, said UK Sinha.
Mar 30, 2015 at 16:22 | Source: PTI
To deepen capital markets, SEBI also pitched for allowing investment of pension money into various securities instruments and to create an enabling environment for REITs to flourish.
Mar 30, 2015 at 14:00 | Source: Moneycontrol.com
The market staged spectacular performance on Monday with the Nifty reclaiming 8500 level and Sensex hitting 28000-mark led by banking & financials, FMCG, capital goods and IT stocks.
Mar 30, 2015 at 12:49 | Source: CNBC-TV18
Watch the interview of Sameet Chavan of Angel Broking with Sumaira Abidi and Reema Tendulkar on CNBC-TV18, in which he shared his readings and outlook on market, specific stocks and sectors.
Mar 30, 2015 at 10:00 | Source: Moneycontrol.com
The market extended gains led by banking & financials, FMCG, telecom, capital goods and technology stocks. The Sensex rose 317.15 points or 1.16 percent to 27775.79 and the Nifty climbed 85.35 points or 1.02 percent to 8426.75.
Mar 29, 2015 at 18:16 | Source: PTI
Amid brewing discontent in the mutual funds industry, capital market regulator Sebi is looking at concerns raised over the proposed one percent cap on upfront commission paid to agents for selling mutual fund schemes.
Mar 29, 2015 at 14:54 | Source: PTI
Rising tensions in the Middle East, liquidity conditions in the market and overall investment trend of foreign funds will largely dictate trend on the bourses in this holiday shortened week, say experts
Mar 29, 2015 at 11:44 | Source: PTI
With overseas investors pumping in over USD 3 billion in the Indian capital markets this month, total foreign inflows have touched USD 13 billion since the beginning of the year.
Mar 27, 2015 at 17:45 | Source: PTI
The company said that J P Morgan and Religare Capital Markets acted as financial advisors to Fortis for the transaction.
Messages on Religare Capital Markets »

Web Messenger

Platinum Member

277807 Followers

Indian indices  

Source:NDTV Profit - 2:30 p.m. Tirthankar Patnaik of Religare Capital Markets says that Nifty has could run up by another 100-150 points before the fundamentals catch up. (Track stocks). All the sectoral indices, except the pharma, are trading higher. Gail India, Tech

4.55 PM Mar 6th 2014

cleverman

Platinum Member

92 Followers

Ranbaxy Labs  

also the stock will have a downside of around 10-15 per cent from these levels. We recommend a sell on the stock," adds Nangra. Arvind Bothra, Vice President, institutional research, Religare Capital Markets, says, "we expect significant negative impact on stock price following this news and reiterate

8.15 PM Jan 24th 2014

BSE/NSE Announcer

Platinum Member

6989 Followers

Crompton Greave  

"). This Advertisement should be read in conjunction with, and in continuation of, the Public Announcement (PA") published on July 04, 2013 and corrigenda to the PA published on July 16, 2013 and November 09,2013 to the shareholders of Crompton Greaves Limited ("Target Company")Religare Capital Markets Ltd

5.45 PM Jan 16th 2014

Web Messenger

Platinum Member

277807 Followers

Ipca Labs  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on pharma space. ET Now: On the entire pharma space, do you think that can still continue to be the big bet into 2014 given

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

277807 Followers

Glenmark  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on pharma space. ET Now: On the entire pharma space, do you think that can still continue to be the big bet into 2014 given

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

277807 Followers

News Now  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on market movement in 2014. ET Now: Last day of 2013, how does that really set stage for what your outlook is in the initial part

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

277807 Followers

Infosys  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on Infosys. ET Now: What makes you bullish on Infosys? Dr Tirthankar Patnaik: We are positive on the whole IT sector and therefore

3.25 PM Dec 31st 2013

DLF  

The central bank will hike repo rate, or the rate at which banks borrow from the central bank (Reserve Bank of India), by a total of 50 basis points (bps) till FY14-end, believes Tirthankar Patnaik, executive vice president- institutional sales, Religare Capital Markets. So it will sock to real

11.52 AM Oct 25th 2013

Infosys  

IT space good buy, Infosys and Tech Mahindra top picks: Gautam Trivedi, MD & Head of Equities, Religare Capital Markets Ltd

2.47 PM Oct 23rd 2013

Infosys  

IT space good buy, Infosys and Tech Mahindra top picks: Gautam Trivedi, MD & Head of Equities, Religare Capital Markets Ltd

2.46 PM Oct 23rd 2013

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.